JCHR

Manuscripts

General

1. Pediatric Diabetes Consortium. Pediatric Diabetes Consortium: Improving care of children with type 1 diabetes through collaborative research. Diabetes Technol Ther 2010 Sep;12(9):685-8 (Published). (Manuscript) |  View Publication

2. Wood JR, Kaminski BM, Kollman C, Beck RW, Hall CA, Yun JP, Cengiz E, Haller MJ, Hassan K, Klingensmith GJ, Tamborlane WV. The Accuracy and Precision of the Axis-Shield Afinion Hemoglobin A1c Measurement Device. J Diabetes Sci Technol 2012 Mar; 6(2): 380-6 (Published). (Manuscript) |  View Publication

3. Klingensmith GJ, Tamborlane WV, Wood JR, Haller MJ, Silverstein J, Cengiz E, Shanmugham S, Kollman C, Wong-Jacobson S, Beck RW; Pediatric Diabetes Consortium. Diabetic Ketoacidosis at diabetes onset: Still an all too common threat in youth. J Pediatr. 2013 Feb;162(2):330-4.e1. doi: 10.1016/j.jpeds.2012.06.058 (Published). (Manuscript) |  View Publication

4. Kaminski BM, Klingensmith GJ, Beck RW, Tamborlane WV, Lee JM, Hassan K, Schatz D, Kollman C, Redondo MJ; Pediatric Diabetes Consortium. Body Mass Index at the Time of Diagnosis of Autoimmune Type 1 Diabetes in Children. J Pediatr. 2013 Apr;162(4):736-740.e1. doi: 10.1016/j.jpeds.2012.09.017 (Published). (Manuscript) |  View Publication

5. Tamborlane WV, Klingensmith G. Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care. 2013 Jun;36(6):1777-8. doi: 10.2337/dc13-0743 (Published). (Manuscript) |  View Publication

6. Redondo MJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Wood JR, Buckingham B, Klingensmith GJ, Silverstein J, Tamborlane WV; Pediatric Diabetes Consortium. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (Neon) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014 Jun;15(4):294-302. doi: 10.1111/pedi.12061 (Published). (Manuscript) |  View Publication

7. Cengiz E, Connor CG, Ruedy KJ, Beck RW, Kollman C, Klingensmith GJ, Tamborlane WV, Lee JM, Haller MJ; Pediatric Diabetes Consortium. Pediatric diabetes consortium T1D New Onset (Neon) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014 Jun;15(4):287-93. doi: 10.1111/pedi.12068 (Published). (Manuscript) |  View Publication

8. Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee Z, Tamborlane WV. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013 Nov;15(11):929-34. doi: 10.1089/dia.2013.0132 (Published). (Manuscript) |  View Publication

9. Gregg B, Connor CG, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Harris B, Tamborlane WV, Klingensmith GJ, Lee JM. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. J Pediatr. 2015 May;166(5):1265-1269.e1. doi: 10.1016/j.jpeds.2015.02.036 (Published). (Manuscript) |  View Publication

10. Gregg B, Connor CG, Cheng P, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Tamborlane WV, Klingensmith GJ, Lee JM. C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2016 Jun;17(4):274-80. doi: 10.1111/pedi.12280 (Published). (Manuscript) |  View Publication

11. Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, Wood JR, Lee JM, Willi SM, Cengiz E, Tamborlane WV. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2016 Jun;17(4):266-73. doi: 10.1111/pedi.12281 (Published). (Manuscript) |  View Publication

12. Silverstein J, Cheng P, Ruedy KJ, Kollman C, Beck RW, Klingensmith GJ, Wood JR, Willi S, Bacha F, Lee J, Cengiz E, Redondo MJ, Tamborlane WV. Depressive symptoms in youth with type 1 or type 2 diabetes: Results of the pediatric diabetes consortium screening assessment of depression in diabetes study. Diabetes Care. 2015 Dec;38(12):2341-3. doi: 10.2337/dc15-0982 (Published). (Manuscript) |  View Publication

13. Wood JR, Connor CG, Cheng P, Ruedy KJ, Tamborlane WV, Klingensmith GJ, Schatz D, Gregg B, Cengiz E, Willi SM, Bacha F, Beck RW. Vitamin D status in youth with Type 1 and Type 2 diabetes enrolled in the pediatric diabetes consortium (PDC) is not worse than youth without diabetes. Pediatr Diabetes. 2016 Dec;17(8):584-591. doi: 10.1111/pedi.12340 (Published). (Manuscript) |  View Publication

14. Nambam B, Silverstein J, Cheng P, Ruedy KJ, Beck RW, Wadwa RP, Klingensmith GJ, Willi SM, Wood JR, Bacha F, Thomas IH, Tamborlane WV. A cross-sectional view of the current state of treatment of youth with Type 2 Diabetes in the US: data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 May;18(3):222-229. doi: 10.1111/pedi.12377 (Published). (Manuscript) |  View Publication

15. Cengiz E, Cheng P, Ruedy KJ, Kollman C, Tamborlane WV, Klingensmith GJ, Gal RL, Silverstein J, Lee J, Redondo MJ, Beck RW. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2016 October;18(7):566-573. doi: 10.1111/pedi.12459 (Published). (Manuscript) |  View Publication

16. Shoemaker A, Cheng P, Gal RL, Kollman C, Tamborlane WV, Klingensmith GJ, Clements MA, Hannon TS, Heptulla R, Less J, Wood J. Predictors of lost to follow-up among children with type 2 diabetes. Horm Res Paediatr. 2017;87(6):377-384. doi: 10.1159/000475595 (Published). (Manuscript) |  View Publication

17. Bacha F, Cheng P, Gal RL, Kollman C, Tamborlane WV, Klingensmith GJ, Manseau K, Wood J, Beck RW. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018;89(1):47-55. doi: 10.1159/000481687 (Published). (Manuscript) |  View Publication

18. Redondo MJ, Libman I, Cheng P, Kollman C, Tosur M, Gal RL, Klingensmith GJ, Clements M. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 May;41(5):1017-1024. doi: 10.2337/dc17-2335 (Accepted). (Manuscript) |  View Publication

19. Klingensmith GJ, Lanzinger S, Tamborlane WV, Hofer S, Cheng P, deBeaufort C, Gal RL, Reinehr T, Kollman C, Holl R. Adolescent Type 2 Diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective Registries.. Pediatr Diabetes. 2018 Nov;19(7):1156-1163. doi: 10.1111/pedi.12712. (Accepted). (Manuscript) |  View Publication

20. Tamborlane WV, Cheng P, Ruedy R, Klingensmith GJ, Gal RL, Van Name M, Bacha F, Willi S, Beck RW. Eligibility for clinical trials is limited for youth with type 2 diabetes (T2D): Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2018 Dec;19(8):1379-1384. doi: 10.1111/pedi.12763 (Accepted). (Manuscript)

Meeting Abstracts

General

1. Klingensmith GJ, Kaminski B, Block J, Cengiz E, Haller MJ, Lee J, Redondo MJ, Wood JR, Tamborlane WV, Beck RW, Pediatric Diabetes Consortium. Obesity and DKA are common in youth at T1D onset: findings of the Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Diego, 2011 (Published). (Poster)

2. Wood JR, Kaminski B, Kollman C, Cengiz E, Haller MJ, Hassan K, Klingensmith GJ, Tamborlane WV, Yun J, Beck RW, Pediatric Diabetes Consortium. The accuracy and precision of the Axis-Shield Afinion HbA1c measurement device. American Diabetes Association meeting; San Diego, 2011 (Published). (Poster)

3. Cengiz E, Kaminski BM, Klingensmith GJ, Haymond M, Lee JM, Tamborlane WV, Pediatric Diabetes Consortium. New insights to an old disease: Major clinical outcomes within first year of diagnosis for youth with type 1 diabetes (T1D) from Pediatric Diabetes Consortium (PDC) cohort. American Diabetes Association meeting; San Diego, 2011 (Published). (Poster)

4. Cengiz E, Kaminski B, Kollman C, Haymond M, Klingensmith G, Lee JM, Tamborlane WV, Pediatric Diabetes Consortium. Frequency of episodes of Diabetic Ketoacidosis (DKA) and Severe Hypoglycemia (SH) during the first year after Diagnosis of type 1 diabetes (T1D). International Society for Pediatric and Adolescent Diabetes meeting; Miami Beach, 2011 (Published). (Poster)

5. Lin MH, Wood JR, Kaminski BM; Pediatric Diabetes Consortium. Race and socioeconomic status are independent predictors of youth receiving insulin pump therapy in the first year of type 1 diabetes (T1D) treatment. International Society for Pediatric and Adolescent Diabetes meeting; Miami Beach, 2011 (Published). (Oral Presentation)

6. Redondo MJ, Kaminski B, Block J, Buckingham B, Cengiz E, Haller MJ, Haymond M, Lee J, Schatz D, Silverstein J, Tamborlane WV, Wood JR, Klingensmith GJ, Pediatric Diabetes Consortium. BMI in children with autoimmune type 1 diabetes. International Society for Pediatric and Adolescent Diabetes meeting; Miami Beach, 2011 (Published). (Oral Presentation)

7. Cengiz E, Buckingham B, Klingensmith GJ, Redondo MJ, Schatz D, Tamborlane WV, Wong-Jacobson S, Kollman C; Pediatric Diabetes Consortium. Partial Remission (PR) during the first 12 months of treatment in youth with type 1 diabetes (T1D) in the Pediatric Diabetes Consortium cohort (PDC). American Diabetes Association meeting; Philadelphia, 2012 (Published). (Poster)

8. Cengiz E, Wong-Jacobson S, Kollman C, Haymond M, Klingensmith GJ, Lee JM, Tamborlane WV; Pediatric Diabetes Consortium. How common are episodes of Diabetic Ketoacidosis (DKA) and Severe Hypoglycemia (SH) in the first year of diagnosis with type 1 diabetes (T1D)?. American Diabetes Association meeting; Philadelphia, 2012 (Published). (Poster)

9. Gregg B, Kollman C, Wong-Jacobson S, Schatz D, Cengiz E, Harris B, Tamborlane WV, Klingensmith GJ, Lee JM; Pediatric Diabetes Consortium. Weight gain in the first year after diagnosis of type 1 diabetes. American Diabetes Association meeting; Philadelphia, 2012 (Published). (Poster)

10. Lin MH, Wood JR, Wong-Jacobson S; Pediatric Diabetes Consortium. Race and socioeconomic status independently predict whether youth receive insulin pump therapy in the first year of type 1 diabetes (T1D) treatment. American Diabetes Association meeting; Philadelphia, 2012 (Published). (Poster)

11. Redondo MJ, Wong-Jacobson S, Buckingham B, Kollman C, Klingensmith GJ, Silverstein J, Tamborlane WV, Wood JR; Pediatric Diabetes Consortium. Characteristics of pediatric type 1 diabetes (T1D) that predict HbA1c at one year. American Diabetes Association meeting; Philadelphia, 2012 (Published). (Poster)

12. Wood JR, Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee JM, Tamborlane WV, Pediatric Diabetes ConsortiumConsortium. Race and socioeconomic status are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. International Conference on Advanced Technologies and Treatments for Diabetes; Paris, 2013 (Published). (Oral Presentation)

13. Cengiz E, Connor CG, Ruedy KJ, Tamborlane WV, Kollman C, Beck RW, Lee JM, Klingensmith GJ, Redondo MJ, Silverstein J; Pediatric Diabetes Consortium. Clinical outcomes in youth within the 2nd year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) T1D New Onset (NeOn) study. American Diabetes Association meeting; Chicago, 2013 (Published). (Poster)

14. Haller MJ, Cengiz E, Tamborlane WV, Roy SM, Thambundit A, Beck RW, Kollman C, Ruedy KJ, Connor CG, Buckingham B, Gregg B, Thomas I, Pediatric Diabetes Consortium. Frequency of self-Monitoring of Blood Glucose (SMBG) and A1c levels in youth with type 2 diabetes (T2D): Data from the Pediatric Diabetes Consortium (PDC) T2D registry. American Diabetes Association meeting; San Francisco, 2014 (Published). (Poster)

15. Klingensmith GJ, Willi SM, Cengiz E, Wood JR, Tamborlane WV, Lee JM, Haro H, Beck RW, Kollman C, Ruedy KJ, Connor CG, Pediatric Diabetes Consortium. Findings at diagnosis of Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D): The Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Francisco, 2014 (Published). (Poster)

16. Silverstein J, Cengiz E, Tamborlane WV, Willi SM, Klingensmith GJ, Shanmugham S, Wood JR, Bacha F, Lee JM, Redondo MJ, Beck RW, Kollman C, Connor CG, Ruedy KJ, Pediatric Diabetes Consortium. Classification of Depression Symptoms in Youth with Type 1 and Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Francisco, 2014 (Published). (Poster)

17. Tamborlane WV, Willi SM, Bacha F, Lee JM, Haymond M, Klingensmith GJ, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Connor CG. Why are trials of new drugs in pediatric T2D failing?. American Diabetes Association meeting; San Francisco, 2014 (Published). (Poster)

18. Wood JR, Bacha F, Willi SM, Cengiz E, Tamborlane WV, Gregg B, Klingensmith GJ, Haro H, Schatz D, Beck RW, Ruedy KJ, Kollman C, Connor CG, Pediatric Diabetes Consortium. Youth with type 2 diabetes (T2D) have more vitamin D deficiency than youth with type 1 diabetes (T1D): the Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Francisco, 2014 (Published). (Poster)

19. Gregg B, Lee JM, Tamborlane WV, Willi SM, Bacha F, Cengiz E, Klingensmith GJ, Beck RW, Ruedy KJ, Kollman C, Connor CG, Pediatric Diabetes Consortium. C-peptide trajectory in children after type 2 diabetes diagnosis. International Society for Pediatric and Adolescent Diabetes meeting; Toronto, 2014 (Published). (Poster)

20. Bacha F, Tamborlane WV, Klingensmith GJ, Cheng P, Gal RL, Kollman C, Beck RW, Manseau K, Wood J, Pediatric Diabetes Consortium. Initial presentation of type 2 diabetes (T2D) in adolescents predicts durability of successful treatment with metformin monotherapy: Insights from the Pediatric Diabetes Consortium (PDC) T2D registry. American Diabetes Association meeting; New Orleans, 2016 (Published). (Oral Presentation)

21. Van Name M, Tamborlane WV, Cheng P, Gal RL, Kollman C, Beck RW, Engle C, Hsu L, Silverstein J, Willi S, Pediatric Diabetes Consortium. Therapeutic inertia: Underdiagnosed Hypertension and Dyslipidemia in the Pediatric Diabetes Consortium (PDC) type 2 diabetes (T2D) registry. American Diabetes Association meeting; New Orleans, 2016 (Published). (Poster)

22. Tamborlane WV, Cheng P, Klingensmith GJ, Gal RL, Kollman C, Van Name M, Bacha F, Willi S, Beck RW. Expanding eligibility for pediatric T2D clinical trials: insights from the Pediatric Diabetes Consortium T2D clinic registry. American Diabetes Association meeting; San Diego, 2017 (Published). (Poster)

23. Klingensmith GJ, Lanzinger S, Tamborlane WV, Holl R, Cheng P, Witsch M, Gal RL, Wiegand S, Kollman C, Hofer S. Characteristics and treatment of youth with T2D at onset: a comparison of the US Pediatric Diabetes Consortium and German/Austrian/Luxemburg Pediatric Diabetes Prospective Follow Up cohorts. American Diabetes Association meeting; San Diego, 2017 (Published). (Poster)

24. Klingensmith GJ, Lanzinger S, Tamborlane WV, Rami-Merhar B, Cheng P, de Beaufort C, Gal RL, Reinehr T, Kollman C, Holl R. Characteristics and treatment of adolescents with type 2 diabetes (T2D): comparison of US Pediatric Diabetes Consortium (PDC) and German/Austrian/Luxemburg Pediatric Diabetes Prospective Follow Up (DPV) cohorts. American Diabetes Association meeting; San Diego, 2017 (Published). (Poster)

25. Nelson B, Cheng P, Tamborlane WV, Klingensmith GJ, Gal RL, Kollman C, Wood J. An updated cross-sectional view of the state of the treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium type 2 diabetes registry. American Diabetes Association meeting; San Diego, 2017 (Published). (Poster)

26. Beaulieu LC, Cheng P, Katz M, Laffel L, Tamborlane WV, Van Name MA, Bansal N, Kollman C, Gal RL. Management of Hypertension and Hyperlipidemia in Youth with T2D. American Diabetes Association meeting; Orlando, 2018. (Accepted). (Poster)

27. Gal RL, Beaulieu LC, Keelin K, Less J, Nelson B, Wintergerst K, Klingensmith G, Tamborlane WV. Transforming Pediatric T2D Clinical Research – A Network Model. American Diabetes Association meeting; Orlando, 2018 (Accepted). (Poster)

28. Klingensmith, GJ, Cheng P, Gal RL, Beaulieu LC, Tamborlane WV, Bacha F, Kelsey MM, Kollman C. Clinical characteristics and antibody persistence over time in youth in the Pediatric Diabetes Consortium (PDC) Type 2 Diabetes (T2D) Cohort. American Diabetes Association meeting; Orlando, 2018 (Accepted). (Poster)

29. Tamborlane WV, Cheng P, Gal RL, Kollman C, Van Name MA, Lynch J, Nelson B. T1D and T2D Youth in the Pediatric Diabetes Consortium: A Comparison of Clinical Characteristics and Glycemic Control. American Diabetes Association meeting; Orlando, 2018 (Accepted). (Poster)

30. Terry AM, Bollepalli S, Smith L, Walker A, Gal RL, Beaulieu LC, Edelen R, Less J. Understanding and Addressing Enrollment Challenges in Pediatric T2D Clinical Trials Compared with T1D. American Diabetes Association meeting; Orlando, 2018 (Accepted). (Meeting Abstract)

31. Wiegand S, Klingensmith GJ, Lanzinger S, Tamborlane WV, Reinehr T, Cheng P, Bauer M, Gal RL, Holl RH, Kollman C. Predictors of loss to follow-up in youth with T2D: Comparing predictors in the US Pediatric Diabetes Consortium and European Pediatric Diabetes Prospective Follow Up cohorts. European Association for the Study of Diabetes meeting; Berlin, 2018 (Accepted). (Poster)

32. Bacha F, Cheng P, Gal RL, Beaulieu LC, Kollman C, Adolph A, Jindal I, Shoemaker A, Wolf R, Klingensmith GJ, Tamborlane WV. Racial Differences in Comorbidities in Youth with T2D in the Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Francisco, 2019 (Accepted). (Poster)

33. Klingensmith GJ, Cheng P, Gal RL, Beaulieu LC, Kollman C, Adams R, Hannon T, Looper L, Tamborlane WV. Healthcare Utilization in T2D Youth in the Pediatric Diabetes Consortium (PDC). American Diabetes Association meeting; San Francisco, 2019 (Accepted). (Poster)

34. Tamborlane WV, Cheng P, Gal RL, Beaulieu LC, Kollman C, Van Name MA, Isganaitis E, Mastrandrea L, Klingensmith GJ. Is drug treatment required in all youth with T2D early in the disease?. American Diabetes Association meeting; San Francisco, 2019 (Accepted). (Meeting Abstract)